The former Aging and Transgenic Animal Core now Proteostasis and Aging Animal Models Core (Core C) and referred in the PP text as ?Animal Core? will continue to support the need for in vivo experimental mouse models of the four projects of this Program Project (PP). The long-term goals of this Core are to provide the projects with a wide repertoire of age-controlled animal models with modified autophagic function and mouse models designed for the in vivo assessment of autophagy activity. These animals have been and will keep being essential for performing studies contained in all four projects that will characterize the consequences of the age-related changes in autophagy on different aspects of cell biology and organ and system function. Furthermore, the core will also supply different mouse models of Alzheimer?s disease used by all projects, which will provide models of central proteotoxicity to characterize how altered proteostasis in the brain may affect proteostatic equilibrium in peripheral tissues and vice versa.
The specific aims of the core are: 1) to generate and maintain i. genetically modified animals with altered autophagy in different tissues; ii. mice expressing autophagy reporters; and iii. genetic models of proteotoxicity in Alzheimer?s disease; 2) to maintain age-controlled colonies of wild-type and genetically modified mice; 3) to serve as a link among the investigators in the Program Project by coordinating the sacrifice of animals to maximize their use and by integrating the information obtained from the different animal models by each investigator; 4) to facilitate uniformity in the mouse interventions incorporated in all the projects during this new period; 5) to collect longitudinal information on some of the transgenic mouse models shared by all projects and integrate the heath-span information from each project in the same animals. Services: The core will continue offering assistance with maintenance of the mouse colonies, coordination of genotyping, administration and monitoring of animal treatments (diets and pharmacological compounds), animal dissection, collection of tissue samples for storage or histopathological analysis and continuous access to a searchable animal data base. Key personnel: the director, who is assisted by the animal technicians. The director supervises all the activities of the Core, approves animal use by the PP members, establishes breeding schemes to accommodate the project needs and oversees animal information input in the database. The technicians perform all of the activities related to the maintenance of the animal colonies, genotyping, treatments, tissue collection, behavioral testing and inputs information into the database. Relevance: The services provided by this core are central to all the activities of the projects included in this PP to understand the role of proteostasis in aging and disease and to develop genetic and chemical interventions to modulate the aging process as a way to prevent or delay Alzheimer?s disease onset. The centralization and sharing of animals optimizes cost efficiency and guarantees integration of information coming from different systems and organs in all animal models used in this study.

Public Health Relevance

All four Projects require the use of similar age-controlled autophagy and CAN proteotoxicity associated with Alzheimer?s disease mouse models, but focus on different tissues. Centralizing the procedures involving animals in the Core: 1) maximizes animal use; 2) offers uniformity across the different projects; and 3) allows integration of the information obtained from different systems by the different projects. The interventions performed by the core to modulate autophagy may help set the basis for future anti-aging interventions.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
2P01AG031782-13A1
Application #
9937028
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2009-02-15
Project End
2025-03-31
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
13
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
081266487
City
Bronx
State
NY
Country
United States
Zip Code
10461
Walters, Ryan O; Arias, Esperanza; Diaz, Antonio et al. (2018) Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans. Cell Rep 25:663-676.e6
Mocholi, Enric; Dowling, Samuel D; Botbol, Yair et al. (2018) Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy. Cell Rep 24:1136-1150
Rodriguez-Muela, Natalia; Parkhitko, Andrey; Grass, Tobias et al. (2018) Blocking p62-dependent SMN degradation ameliorates spinal muscular atrophy disease phenotypes. J Clin Invest 128:3008-3023
Tekirdag, Kumsal; Cuervo, Ana Maria (2018) Chaperone-mediated autophagy and endosomal microautophagy: Joint by a chaperone. J Biol Chem 293:5414-5424
Theofilas, Panos; Ehrenberg, Alexander J; Nguy, Austin et al. (2018) Probing the correlation of neuronal loss, neurofibrillary tangles, and cell death markers across the Alzheimer's disease Braak stages: a quantitative study in humans. Neurobiol Aging 61:1-12
Kaushik, Susmita; Cuervo, Ana Maria (2018) The coming of age of chaperone-mediated autophagy. Nat Rev Mol Cell Biol 19:365-381
Amengual, Jaume; Guo, Liang; Strong, Alanna et al. (2018) Autophagy Is Required for Sortilin-Mediated Degradation of Apolipoprotein B100. Circ Res 122:568-582
Bejarano, Eloy; Murray, John W; Wang, Xintao et al. (2018) Defective recruitment of motor proteins to autophagic compartments contributes to autophagic failure in aging. Aging Cell :e12777
Gong, Zhenwei; Tasset, Inmaculada; Diaz, Antonio et al. (2018) Humanin is an endogenous activator of chaperone-mediated autophagy. J Cell Biol 217:635-647
Dowling, Samuel D; Macian, Fernando (2018) Autophagy and T cell metabolism. Cancer Lett 419:20-26

Showing the most recent 10 out of 147 publications